ArticlePloS one2025
Impact of geopolitical risks and innovation on global defense stock return.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study conducts a comparative analysis of how geopolitical risk (GPR) and innovation impact stock returns in the defense industry based on data from 75 defense companies across 17 countries and 4 continents. With daily datasets spanning from January 1, 2014 to March 29, 2024, wavelet coherence and wavelet phase differences were used to conduct the analysis. The results revealed that innovation had a greater and more pronounced impact during the entire analysis period compared with the influence of GPR events. GPRs exerted an uneven and heterogeneous impact on global defense stocks and had a concentrated impact during events that generated uncertainty. Overall, we found significant time-varying dependence across a large number of companies at different time frequencies. The COVID-19 pandemic did not have a major impact on companies in the defense industry. Further, GPR events led to increased volatility during the Russia-Ukraine war, leading to increased uncertainty. In addition to the dominant role they play in the world defense market, US companies served as a robust hedge, especially from 2021 to 2022. Defense companies in the UK are more sensitive to both GPR events and innovation, followed by companies in Germany and France. Comparative analysis of the scalograms of China reveals a greater influence of innovation compared with GPR events. Thus, diversification opportunities have been extended from the defense industry in China, offering investors a promising way to capitalize on refuge opportunities during periods of disruption. To mitigate the global rearmament trend, we suggest alternative investment opportunities for different time horizons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.